Controlled Drug Delivery of Hydrophobic Drug: Development and Evaluation of Oral Controlled Drug Delivery of BCS Class-II Drug Glipizide - Couverture souple

Jagtap, Rajesh ; Jagtap, Sneha ; Chavan, Sandeep

9786202518062: Controlled Drug Delivery of Hydrophobic Drug: Development and Evaluation of Oral Controlled Drug Delivery of BCS Class-II Drug Glipizide

Couverture souple

ISBN 10 : 6202518065 ISBN 13 : 9786202518062

Editeur : LAP LAMBERT Academic Publishing, 2020

Afficher les exemplaires de cette �dition comportant l?ISBN

0 D'occasion

6 Neuf

De EUR 54,90

Glipizide, an oral hypoglycemic agent, is one of the most commonly prescribed drugs for the treatment of patients with type II diabetes mellitus. It is practically water-insoluble, thus it belongs to class-II of Biopharmaceutical Classification System (BCS). Glipizide has a relatively short elimination half-life (2–4 h), thereby requiring twice daily dosing in large number of patients, which often leads to non-compliance. Thus, there is a strong clinical need and market potential for a dosage form that will deliver glipizide in a controlled manner to a patient needing this therapy, thereby resulting in a better patient compliance. The aim of present investigation was to enhance the solubility by using β-cyclodextrin binary complexation and impart a controlled release in a single formulation in order to reduce dosing frequency.

Les informations fournies dans la section � Synopsis � peuvent faire r�f�rence � une autre �dition de ce titre.

�diteur: LAP LAMBERT Academic Publishing
Date d'�dition: 2020
Langue: anglais
ISBN 10: 6202518065
ISBN 13: 9786202518062
Reliure: Broch�
Nombre de pages: 96
Coordonn�es du fabricant: non disponible
Personne responsable: KreGa Onlinehandel GmbH
4950000000000
info@krega-onlinehandel.de

Birkenweg 31
Brakel
33034
Allemagne

R�sultats de recherche pour Controlled Drug Delivery of Hydrophobic Drug: Development...

Image fournie par le vendeur

Controlled Drug Delivery of Hydrophobic Drug

Rajesh Jagtap

Edit� par LAP LAMBERT Academic Publishing Mrz 2020, 2020

ISBN 10 : 6202518065 ISBN 13 : 9786202518062

Neuf Taschenbuch

impression � la demande

Vendeur : BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Allemagne

�valuation du vendeur 5 sur 5 �toiles

Taschenbuch. Etat : Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Glipizide, an oral hypoglycemic agent, is one of the most commonly prescribed drugs for the treatment of patients with type II diabetes mellitus. It is practically water-insoluble, thus it belongs to class-II of Biopharmaceutical Classification System (BCS). Glipizide has a relatively short elimination half-life (2-4 h), thereby requiring twice daily dosing in large number of patients, which often leads to non-compliance. Thus, there is a strong clinical need and market potential for a dosage form that will deliver glipizide in a controlled manner to a patient needing this therapy, thereby resulting in a better patient compliance. The aim of present investigation was to enhance the solubility by using beta-cyclodextrin binary complexation and impart a controlled release in a single formulation in order to reduce dosing frequency. 96 pp. Englisch. N� de r�f. du vendeur 9786202518062

Contacter le vendeur

Acheter neuf

EUR 54,90

Exp�dition �EUR 23
Exp�dition depuis Allemagne vers Etats-Unis

Quantit� disponible : 2 disponible(s)

Ajouter au panier

Image fournie par le vendeur

Controlled Drug Delivery of Hydrophobic Drug

Rajesh Jagtap|Sneha Jagtap|Sandeep Chavan

Edit� par LAP LAMBERT Academic Publishing, 2020

ISBN 10 : 6202518065 ISBN 13 : 9786202518062

Neuf Couverture souple

impression � la demande

Vendeur : moluna, Greven, Allemagne

�valuation du vendeur 5 sur 5 �toiles

Etat : New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Autor/Autorin: Jagtap RajeshMr. Rajesh Jagtap is currently working as an Assistant Professor & Vice-Principal at Annasaheb Dange college of B Pharmacy, Ashta. He has a total of 11 years teaching experience. He has published more than 20 papers in . N� de r�f. du vendeur 385945588

Contacter le vendeur

Acheter neuf

EUR 45,45

Exp�dition �EUR 48,99
Exp�dition depuis Allemagne vers Etats-Unis

Quantit� disponible : Plus de 20 disponibles

Ajouter au panier

Image fournie par le vendeur

Controlled Drug Delivery of Hydrophobic Drug

Rajesh Jagtap

Edit� par LAP LAMBERT Academic Publishing M�r 2020, 2020

ISBN 10 : 6202518065 ISBN 13 : 9786202518062

Neuf Taschenbuch

impression � la demande

Vendeur : buchversandmimpf2000, Emtmannsberg, BAYE, Allemagne

�valuation du vendeur 5 sur 5 �toiles

Taschenbuch. Etat : Neu. This item is printed on demand - Print on Demand Titel. Neuware -Glipizide, an oral hypoglycemic agent, is one of the most commonly prescribed drugs for the treatment of patients with type II diabetes mellitus. It is practically water-insoluble, thus it belongs to class-II of Biopharmaceutical Classification System (BCS). Glipizide has a relatively short elimination half-life (2-4 h), thereby requiring twice daily dosing in large number of patients, which often leads to non-compliance. Thus, there is a strong clinical need and market potential for a dosage form that will deliver glipizide in a controlled manner to a patient needing this therapy, thereby resulting in a better patient compliance. The aim of present investigation was to enhance the solubility by using �-cyclodextrin binary complexation and impart a controlled release in a single formulation in order to reduce dosing frequency.VDM Verlag, Dudweiler Landstra�e 99, 66123 Saarbr�cken 96 pp. Englisch. N� de r�f. du vendeur 9786202518062

Contacter le vendeur

Acheter neuf

EUR 54,90

Exp�dition �EUR 60
Exp�dition depuis Allemagne vers Etats-Unis

Quantit� disponible : 1 disponible(s)

Ajouter au panier

Image fournie par le vendeur

Controlled Drug Delivery of Hydrophobic Drug : Development and Evaluation of Oral Controlled Drug Delivery of BCS Class-II Drug Glipizide

Rajesh Jagtap

Edit� par LAP LAMBERT Academic Publishing, 2020

ISBN 10 : 6202518065 ISBN 13 : 9786202518062

Neuf Taschenbuch

impression � la demande

Vendeur : AHA-BUCH GmbH, Einbeck, Allemagne

�valuation du vendeur 5 sur 5 �toiles

Taschenbuch. Etat : Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Glipizide, an oral hypoglycemic agent, is one of the most commonly prescribed drugs for the treatment of patients with type II diabetes mellitus. It is practically water-insoluble, thus it belongs to class-II of Biopharmaceutical Classification System (BCS). Glipizide has a relatively short elimination half-life (2-4 h), thereby requiring twice daily dosing in large number of patients, which often leads to non-compliance. Thus, there is a strong clinical need and market potential for a dosage form that will deliver glipizide in a controlled manner to a patient needing this therapy, thereby resulting in a better patient compliance. The aim of present investigation was to enhance the solubility by using beta-cyclodextrin binary complexation and impart a controlled release in a single formulation in order to reduce dosing frequency. N� de r�f. du vendeur 9786202518062

Contacter le vendeur